Beta Bionics (NASDAQ:BBNX) Coverage Initiated at LADENBURG THALM/SH SH

Stock analysts at LADENBURG THALM/SH SH initiated coverage on shares of Beta Bionics (NASDAQ:BBNX) in a research note issued on Thursday, MarketBeat reports. The firm set a “neutral” rating and a $20.00 price target on the stock. LADENBURG THALM/SH SH’s price target points to a potential downside of 2.77% from the company’s previous close.

Separately, Robert W. Baird started coverage on Beta Bionics in a research report on Thursday. They set a “neutral” rating and a $20.00 target price on the stock.

Beta Bionics Trading Down 1.4 %

BBNX stock opened at $20.57 on Thursday. Beta Bionics has a one year low of $20.57 and a one year high of $24.50.

Insider Transactions at Beta Bionics

In other news, major shareholder Hadley Harbor Aggre Wellington acquired 1,000,000 shares of the stock in a transaction that occurred on Friday, January 31st. The shares were bought at an average cost of $17.00 per share, for a total transaction of $17,000,000.00. Following the acquisition, the insider now owns 3,901,599 shares in the company, valued at approximately $66,327,183. This represents a 34.46 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mike Mensinger acquired 33,350 shares of the business’s stock in a transaction on Friday, January 31st. The shares were purchased at an average price of $17.00 per share, with a total value of $566,950.00. Following the completion of the purchase, the insider now owns 59,019 shares in the company, valued at $1,003,323. This represents a 129.92 % increase in their position. The disclosure for this purchase can be found here.

About Beta Bionics

Beta Bionics, Inc is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.